Patent intelligence · US
US 12187804
Multivalent and multispecific 41BB-binding proteins
Multivalent and multispecific 41BB-binding proteins
Patent details — US 12187804
- Jurisdiction
- US
- Status
- granted
- Grant date
- Jan 7, 2025
- Expiration
- Jan 2, 2045
- Applicant
- Inhibrx Biosciences, Inc.
- Claims
- 12
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P37/04
Quick answer
US 12187804 (Multivalent and multispecific 41BB-binding proteins) is held by Inhibrx Biosciences, Inc.. Status: granted. Granted Jan 7, 2025. Expires Jan 2, 2045 (18 years remaining) — relevant for patent-cliff and LOE planning.
Key facts
- Applicant
- Inhibrx Biosciences, Inc.
- Grant date
- Expiration
- Claims
- 12
- CPC classes
- A61P, A61P29/00, A61P35/00, A61P37/04, A61P43/00
More from Inhibrx Biosciences, Inc.
Related pharmaceutical patents in our USPTO index.
-
US 12365728
DLL3 single domain antibodies and therapeutic compositions thereof
granted -
US 12331132
Multispecific polypeptide constructs having constrained CD3 binding and related methods and uses
granted -
US 12331126
OX40-binding polypeptides and uses thereof
granted -
US 12227584
Multivalent and multispecific OX40-binding fusion proteins
granted -
US 12084502
CD33-binding polypeptides and uses thereof
granted -
US 12043667
CLEC12a binding polypeptides and uses thereof
granted -
US 12012459
OX40-binding polypeptides and uses thereof
granted
Frequently asked questions
What is US patent 12187804?
US 12187804 (Multivalent and multispecific 41BB-binding proteins) is held by Inhibrx Biosciences, Inc.. Status: granted. Granted Jan 7, 2025. Expires Jan 2, 2045 (18 years remaining) — relevant for patent-cliff and LOE planning.
Who owns US 12187804?
Inhibrx Biosciences, Inc. is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 35 pharmaceutical patents for this assignee.
When does US 12187804 expire?
Our index shows an expiration date of Jan 2, 2045 (18 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.